Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)

NCT01659138 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT01659138
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01659138 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Lead sponsor
Sanofi
Phase
Phase 2
Overall status
Terminated
Start date
August 31, 2012
Completion date
April 30, 2016
Enrollment
28 (actual)
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

ulcerative colitis